aod9604 use A0D9604 AOD-9604 5mg & 10mg |

Individual results vary based on baseline metabolic health, lifestyle factors, and protocol adherence

From a theoretical pharmacological standpoint, combining a peptide with putative lipolytic activity (AOD 9604) with a potent triple incretin receptor agonist (retatrutide) could potentially amplify metabolic effects but this is speculative and raises the possibility of compounding adverse effects with no safety data to guide dosing or monitoring

Infertility can also occur in individuals with insufficient B12

Certain vitamins cannot be given in an iv, such as CoQ10 or Vitamin D (oil based)

This designation allows the use of this chemical strictly for in-vitro laboratory testing and experimentation